Comparative in vitro activity of cefpirome and cefepime, two new cephalosporins
- 1 September 1990
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 9 (9), 677-685
- https://doi.org/10.1007/bf01964272
Abstract
In in vitro tests the broad-spectrum cephalosporins cefpirome and cefepime were highly active againstEnterobacteriaceae, although often less so against strains resistant to amoxicillin-clavulanate and ticarcillin-clavulanate, and against most strains ofAcinetobacter spp. andAeromonas hydrophila. They were also active againstPseudomonas aeruginosa, although strains with non-plasmid mediated beta-lactam resistance were sometimes less sensitive. OtherPseudomonas spp. varied in their sensitivity. Both agents were highly active againstHaemophilus influenzae, but beta-lactamase-producingBranhamella catarrhalis were somewhat less sensitive.Neisseria gonorrhoeae were susceptible, although non-beta-lactamase producing penicillin-resistant strains had higher MICs.Gardnerella vaginalis was also susceptible andCampylobacter coli/jejuni usually susceptible. Both antibiotics had good activity againstStaphylococcus aureus and coagulase-negative staphylococci except for methicillin-resistant strains andStaphylococcus haemolyticus which were of borderline sensitivity. All streptococci were sensitive, with the exception of highly penicillin-resistant pneumococci and enterococci against which cefpirome had greater activity than cefepime. Both antibiotics had little useful activity against theBacteroides fragilis group orBacteroides oralis group but were active against most other anaerobes.Clostridium difficile and some otherClostridium species were resistant.Keywords
This publication has 6 references indexed in Scilit:
- Breakpoints in in-vitro antibiotic sensitivity testing. Report by a working party of the British Society for Antimicrobial Chemotherapy.1988
- Breakpoints in in-vitro antibiotic sesitivity testingJournal of Antimicrobial Chemotherapy, 1988
- The in vitro activity and beta-lactamase stability of cefpirome (HR 810), a pyridine cephalosporin agent active against staphylococci, enterobacteriaceae and pseudomonas aeruginosaInfection, 1985
- Comparison of a new cephalosporin, BMY 28142, with other broad-spectrum beta-lactam antibioticsAntimicrobial Agents and Chemotherapy, 1985
- In vitro evaluation of HR810, a new wide-spectrum aminothiazolyl alpha-methoxyimino cephalosporinAntimicrobial Agents and Chemotherapy, 1984
- The in nitro antibacterial activity of cefotaxime compared with that of cefuroxime and cefoxitinJournal of Antimicrobial Chemotherapy, 1980